Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ib/II study of gimatecan (ST1481) in small cell lung cancer after failure of first-line platinum chemotherapy
CTR20201690Phase 2Active
- Sponsor
- Zhaoke Ophthalmology
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gimatecan in small cell lung cancer (SCLC), sponsored by Zhaoke Ophthalmology. Started Nov 2020; status: active.
02
Drugs
gimatecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on CTR20201690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201690.